PIPA: a phase Ib study of beta-isoform sparing phosphatidylinositol 3-kinase (PI3K) inhibitor taselisib (T) plus palbociclib (P) and fulvestrant (FUL) in PIK3CA-mutant (mt) ER-positive and taselisib (T) plus palbociclib (P) in PIK3CA-mutant (mt) ER-negative advanced breast cancer
dc.contributor.author | Pascual, J | |
dc.contributor.author | MacPherson, IR | |
dc.contributor.author | Armstrong, Anne C | |
dc.contributor.author | Ward, SE | |
dc.contributor.author | Parmar, M | |
dc.contributor.author | Turner, AJ | |
dc.contributor.author | Bye, H | |
dc.contributor.author | Proszek, P | |
dc.contributor.author | Dodson, A | |
dc.contributor.author | Garcia-Murillas, I | |
dc.contributor.author | King, J | |
dc.contributor.author | Hall, E | |
dc.contributor.author | Finneran, L | |
dc.contributor.author | Lopez, JS | |
dc.contributor.author | Okines, AFC | |
dc.contributor.author | Ring, AE | |
dc.contributor.author | Turner, NC | |
dc.date.accessioned | 2019-11-19T16:01:07Z | |
dc.date.available | 2019-11-19T16:01:07Z | |
dc.date.issued | 2019 | en |
dc.identifier.citation | Pascual J, MacPherson IR, Armstrong AC, Ward SE, Parmar M, Turner AJ, et al. PIPA: a phase Ib study of ?-isoform sparing phosphatidylinositol 3-kinase (PI3K) inhibitor taselisib (T) plus palbociclib (P) and fulvestrant (FUL) in PIK3CA-mutant (mt) ER-positive and taselisib (T) plus palbociclib (P) in PIK3CA-mutant (mt) ER-negative advanced breast cancer. J Clin Oncol. 2019;37(15_suppl):1051-. | en |
dc.identifier.doi | 10.1200/JCO.2019.37.15_suppl.1051 | en |
dc.identifier.uri | http://hdl.handle.net/10541/622460 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.1051 | en |
dc.title | PIPA: a phase Ib study of beta-isoform sparing phosphatidylinositol 3-kinase (PI3K) inhibitor taselisib (T) plus palbociclib (P) and fulvestrant (FUL) in PIK3CA-mutant (mt) ER-positive and taselisib (T) plus palbociclib (P) in PIK3CA-mutant (mt) ER-negative advanced breast cancer | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Royal Marsden Hospital and The Institute of Cancer Research, London | en |
dc.identifier.journal | Journal of Clinical Oncology | en |